Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

por Stensgaard, Simone, Thomsen, Astrid, Helstrup, Sofie, Meldgaard, Peter, Sorensen, Boe S.
Publicado 2023

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer p...

por Maansson, Christoffer T., Helstrup, Sofie, Ebert, Eva B. F., Meldgaard, Peter, Sorensen, Boe S.
Publicado 2023